![Yu Shen Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yu Shen Hsu is currently working as the GM, Director, Head-Research & Development at Advagene Biopharma Co., Ltd. Prior to this, Dr. Hsu obtained a doctorate degree from the University of Oxford.
| Società | Posizione | Inizio |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Amministratore Delegato | 20/06/2019 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 2 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advagene Biopharma Co., Ltd.
 Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
